This sugar-coated therapy boosted survival against deadly brain cancer by 50% in mice
Scientists at Oregon State University created sugar-coated lipid nanoparticles that can cross the blood-brain barrier to deliver genetic therapy to glioblastoma tumors. In mouse models, this targeted approach increased survival rates by 50% by effectively suppressing tumor growth.
Why it matters
Glioblastoma is notoriously difficult to treat due to the blood-brain barrier; this delivery method could significantly improve outcomes for aggressive brain cancers.
Researchers at Oregon State University have developed a promising experimental strategy for treating glioblastoma, the most aggressive form of brain cancer. Fewer than 30% of patients survive for two years after diagnosis.
The work, led by Oleh Taratula, Olena Taratula and Yoon Tae Goo of the OSU College of Pharmacy, focuses on two major problems that have long limited glioblastoma treatment. First, therapies must cross the blood-brain barrier, a tightly controlled network of cells that protects the central nervous system from substances circulating in the bloodstream. Second, the treatment must reach tumor cells without affecting healthy tissue.
Sugar-Coated Nanoparticles Target Brain Tumors
In a mouse model, the researchers tested lipid nanoparticles filled with genetic material designed to restore the body's ability to suppress tumor growth. The particles were then covered with a sugar coating that helped them enter the brain and concentrate inside tumors.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in